Paper Alert

Por Messing, Edward M.
Publicado no Bl Cancer (2015)

Paper Alert

Por Messing, Edward M.
Publicado no Bl Cancer (2016)

Paper Alert

Por Messing, Edward M.
Publicado no Bl Cancer (2016)

Beyond Cisplatin – I

Por Messing, Edward M.
Publicado no Bl Cancer (2016)

Checkpoint Inhibitors for Advanced Bladder Cancer

Por Messing, Edward M.
Publicado no Bladder Cancer (2016)

A More Thorough Transurethral Resection

Por Messing, Edward M.
Publicado no Bladder Cancer (2017)

Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria

Por Trivedi, Deep, Messing, Edward M
Publicado em 2009

Cancer Care Economics of Bladder Cancer: Cost-Enhancing Factors and Possible Cost Reduction

Por Noyes, Katia, Singer, Eric A., Messing, Edward M.
Publicado em 2008

VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α

Por Li, Zaibo, Wang, Dakun, Messing, Edward M, Wu, Guan
Publicado em 2005

E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis

Por Yasmin-Karim, Sayeda, King, Michael R., Messing, Edward M., Lee, Yi-Fen
Publicado no Oncotarget (2014)

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells

Por Zhang, Yu, Ni, Jing, Messing, Edward M., Chang, Eugene, Yang, Chin-Rang, Yeh, Shuyuan
Publicado em 2002

The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1α transcriptional activity

Por Li, Zaibo, Wang, Dakun, Na, Xi, Schoen, Susan R., Messing, Edward M., Wu, Guan
Publicado em 2003

A Case Series of Transformation of Teratoma to Primitive Neuroectodermal Tumor: Evolving Management of a Rare Malignancy

Por Dunne, Richard F., Sahasrabudhe, Deepak M., Messing, Edward M., Jean-Gilles, Jerome, Fung, Chunkit
Publicado em 2014

Role of frozen section analysis of testicular/paratesticular fibrous pseudotumours: a five-case experience

Por Gordetsky, Jennifer, Findeis-Hosey, Jennifer, Erturk, Erdal, Messing, Edward M., Yao, Jorge L., Miyamoto, Hiroshi
Publicado em 2011

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’

Por Ptaszynska, Agata, Cohen, Samuel M., Messing, Edward M., Reilly, Timothy P., Johnsson, Eva, Johnsson, Kristina
Publicado no Diabetes Ther (2015)

Complete Remission of Locally Advanced Penile Squamous Cell Carcinoma after Multimodality Treatment

Por Meng, Yifan, Bernie, Helen Levey, Weng, Tzu-Hua, Ling, Dean-An, Messing, Edward M., Guancial, Elizabeth
Publicado no Rare Tumors (2016)

Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men

Por Zhang, Hong, Messing, Edward M., Travis, Lois B., Hyrien, Ollivier, Chen, Rui, Milano, Michael T., Chen, Yuhchyau
Publicado em 2013

Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line

Por Klover Peter, Messing Edward M, Sowden Mark P, Reeder Jay E, Villa-Moruzzi Emma, Ludlow John W
Publicado em 2003-07-01

Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line

Por Reeder, Jay E, Sowden, Mark P, Messing, Edward M, Klover, Peter, Villa-Moruzzi, Emma, Ludlow, John W
Publicado em 2003

Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer

Por Silvers, Christopher R., Liu, Yu-Ru, Wu, Chia-Hao, Miyamoto, Hiroshi, Messing, Edward M., Lee, Yi-Fen
Publicado no Oncotarget (2016)